Abstract
This paper traces the experimental, clinical and mathematical modeling efforts to understand a periodic hematological disease—cyclical neutropenia. It is primarily a highly personal account by two scientists from quite different backgrounds of their interactions over almost 40 years and their attempts to understand this intriguing disease. It’s also a story of their efforts to offer effective treatments for the patients who suffer from cyclic neutropenia and other conditions causing neutropenia and infections.
Similar content being viewed by others
References
Alangari AA, Alsultan A, Osman ME, Anazi S, Alkuraya FS (2013) A novel homozygous mutation in G6PC3 presenting as cyclic neutropenia and severe congenital neutropenia in the same family. J Clin Immunol 33:1403–1406
Apostu R, Mackey MC (2008) Understanding cyclical thrombocytopenia: a mathematical modeling approach. J Theor Biol 251:297–316
Aprikyan AA, Liles WC, Rodger E, Jonas M, Chi EY, Dale DC (2001) Impaired survival of bone marrow hematopoietic progenitor cells in cyclic neutropenia. Blood 97(1):147–153
Aprikyan AA, Kutyavin T, Stein S, Aprikian P, Rodger E, Liles WC, Boxer LA, Dale DC (2003) Cellular and molecular abnormalities in severe congenital neutropenia predisposing to leukemia. Exp Hematol 31(5):372–381
Barrachina Barbera L, Perez Martinez A, Leon Garcia S, Pronzato Cuello F, Martin Arenos J, Toornador E (2005) Cyclic neutropenia with anti-NA2 antibodies and treatment with recombinant granulocyte colony-stimulating factor. An Pediatr (Barc) 63:180–182
Bernard S, Belair J, Mackey M (2003) Oscillations in cyclical neutropenia: new evidence based on mathematical modeling. J Theor Biol 223:283–298
Bonilla MA, Dale D, Zeidler C, Last L, Reiter A, Ruggeiro M, Davis M, Koci B, Hammond W, Gillio A (1994) Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (r-metHuG-CSF) in patients with severe congenital neutropenias. Br J Haematol 88(4):723–730
Brooks G, Provencher G, Lei J, Mackey MC (2012) Neutrophil dynamics after chemotherapy and G-CSF: the role of pharmacokinetics in shaping the response. J Theor Biol 315:97–109
Bunn H (2013) Erythropoietin. Cold Spring Harb Perspect Med 3(a011):619
Burns F, Tannock I (1970) On the existence of a G\(_0\) phase in the cell cycle. Cell Tissue Kinet 3:321–334
Christopher MJ, Link DC (2007) Regulation of neutrophil homeostasis. Curr Opin Hematol 14(1):3–8
Colijn C, Mackey M (2005a) A mathematical model of hematopoiesis: I. Periodic chronic myelogenous leukemia. J Theor Biol 237:117–132
Colijn C, Mackey M (2005b) A mathematical model of hematopoiesis: II. Cyclical neutropenia. J Theor Biol 237:133–146
Colijn C, Foley C, Mackey MC (2007) G-CSF treatment of canine cyclical neutropenia: a comprehensive mathematical model. Exper Hematol 35:898–907
Craig M, Humphries A, Bélair J, Li J, Mackey M, Nekka F (2014) Mechanistic-based translational model for the optimisation of the concurrent use of rhG-CSF and chemotherapeutic agents. J Theor Biol (submitted)
Crawford J, Ozer H, Stoller R, Johnson D, Lyman G, Tabbara I, Kris M, Grous J, Picozzi V, Rausch G (1991) Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med 325(3):164–170
Dale D (2013) Myelosuppression. In: Sonis S, Keefer D (eds) Pathobiology of cancer regimen-related toxicities. Springer-Verlag, New York, pp 187–205
Dale D, Kelley M, Makaryan V, Rodger E, Otto B, Bolyard A (2013) A feasibility study of home monitoring of blood neutrophil counts in patients with chronic neutropenia. In: European Hematology Association (EHA) Annual Meeting Abstracts, European Hematology Association, p P1027
Dale DC, Graw RG (1974) Transplantation of allogenic bone marrow in canine cyclic neutropenia. Science 183:83–84
Dale DC, Hammond WP (1988a) Cyclic neutropenia: a clinical review. Blood Rev 2(3):178–185
Dale DC, Hammond WP (1988b) Cyclic neutropenia: A clinical review. Blood Rev 2:178–185
Dale DC, Ward SB, Kimball JR, Wolff SM (1972) Studies of neutrophil production and turnover in grey collie dogs with cyclic neutropenia. J Clin Invest 51:2190–2196
Dale DC, Bonilla MA, Davis MW, Nakanishi AM, Hammond WP, Kurtzberg J, Wang W, Jakubowski A, Winton E, Lalezari P (1993) A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood 81(10):2496–2502
Dale DC, Person RE, Bolyard AA, Aprikyan AG, Bos C, Bonilla MA, Boxer LA, Kannourakis G, Zeidler C, Welte K, Benson KF, Horwitz M (2000) Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood 96(7):2317–2322
Dale DC, Bolyard AA, Schwinzer BG, Pracht G, Bonilla MA, Boxer L, Freedman MH, Donadieu J, Kannourakis G, Alter BP, Cham BP, Winkelstein J, Kinsey SE, Zeidler C, Welte K (2006) The severe chronic neutropenia international registry: 10-year follow-up report. Support Cancer Ther 3(4):220–231
Dale DD, Brown C, Carbone P, Wolff S (1971) Cyclic urinary leukopoietic activity in gray collie dogs. Science 173:152–153
Erbagci Z (2003) Noma-like gangrenous cheilitis in a child with cyclic neutropenia associated with myeloperoxidase deficiency. Pediatr Dermatol 20(6):519–523
Erslev A (1991) Erythropoietin. N Engl J Med 324:1339–1344
Foley C, Mackey MC (2009a) Dynamic hematological disease: a review. J Math Biol 58:285–322
Foley C, Mackey MC (2009b) Mathematical model for G-CSF administration after chemotherapy. J Theor Biol 257(1):27–44
Foley C, Bernard S, Mackey MC (2006) Cost-effectve G-CSF therapy strategies for cyclical neutropenia: mathematical modelling based hypotheses. J Theor Biol 238(4):754–763
Fortin P, Mackey M (1999) Periodic chronic myelogenous leukemia: spectral analysis of blood cell counts and etiological implications. Brit J Haematol 104:336–345 Please check the page numbers for reference [32].
Guerry D, Dale D, Omine DC, Perry S, Wolff SM (1973) Periodic hematopoiesis in human cyclic neutropenia. J Clin Inves 52:3220–3230
Hammond WP, Price TH, Souza LM, Dale DC (1989) Treatment of cyclic neutropenia with granulocyte colony-stimulating factor. N Engl J Med 320(20):1306–1311
Hammond WP, Csiba E, Canin A, Hockman H, Souza LM, Layton JE, Dale DC (1991) Chronic neutropenia. A new canine model induced by human granulocyte colony-stimulating factor. J Clin Invest 87(2):704–710
Haurie C, Mackey MC, Dale DC (1998) Cyclical neutropenia and other periodic hematological diseases: a review of mechanisms and mathematical models. Blood 92:2629–2640
Haurie C, Dale DC, Mackey MC (1999a) Occurrence of periodic oscillations in the differential blood counts of congenital, idiopathic, and cyclical neutropenic patients before and during treatment with G-CSF. Exp Hematol 27:401–409
Haurie C, Person R, Dale DC, Mackey M (1999) Haematopoietic dynamics in grey collies. Exper Hematol 27:1139–1148
Haurie C, Dale DC, Rudnicki R, Mackey MC (2000) Modeling complex neutrophil dynamics in the grey collie. J Theor Biol 204:504–519
Hearn T, Haurie C, Mackey M (1998) Cyclical neutropenia and the peripherial control of white blood cell production. J Theor Biol 192:167–181
Hitchcock I, Kaushansky K (2014) Thrombopoietin from beginning to end. Br J Haematol 165:259–268
Horwitz M, Benson KF, Person RE, Aprikyan AG, Dale DC (1999) Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis. Nat Genet 23(4):433–436
Kaushansky K (2006) Lineage-specific hematopoietic growth factors. N Engl J Med 354(19):2034–2045
Kazarinoff ND, van den Driessche P (1979) Control of oscillations in hematopoiesis. Science 203:1348–1350
King-Smith EA, Morley A (1970) Computer simulation of granulopoiesis: normal and impaired granulopoiesis. Blood 36:254–262
Kollner I, Sodeik B, Schreek S, Heyn H, von Neuhoff N, Germeshausen M, Zeidler C, Kruger M, Schlegelberger B, Welte K, Beger C (2006) Mutations in neutrophil elastase causing congenital neutropenia lead to cytoplasmic protein accumulation and induction of the unfolded protein response. Blood 108(2):493–500
Lei J, Mackey M (2007) Stochastic differential delay equation, moment stability, and application to hematopoietic stem cell regulation system. SIAM J Appl Math 67:387–407
Lei J, Mackey MC (2011) Multistability in an age-structured model of hematopoiesis: cyclical neutropenia. J Theor Biol 270:143–153
Lei J, Levin S, Nie Q (2014) Mathematical model of adult stem cell regeneration with cross-talk between genetic and epigenetic regulation. Proc Natl Acad Sci USA 111:880–887
Lomb NR (1976) Least-squares frequency analysis of unequally spaced data. Astrophys Space Sci 39:447–462
Lund JE, Padgett GA, Ott RL (1967) Cyclic neutropenia in grey collie dogs. Blood 29(4):452–461
MacDonald N (1978) Cyclical neutropenia: models with two cell types and two time lags. In: Valleron A, Macdonald P (eds) Biomathematics and cell kinetics. Elsevier/North-Holland, Amsterdam, pp 287–295
Mackey MC (1978a) A unified hypothesis for the origin of aplastic anemia and periodic haematopoiesis. Blood 51:941–956
Mackey MC (1978b) A unified hypothesis for the origin of aplastic anemia and periodic haematopoiesis. Blood 51:941–956
Mackey MC (1979) Dynamic haematological disorders of stem cell origin. In: Vassileva-Popova JG, Jensen EV (eds) Biophysical and biochemical information transfer in recognition. Plenum Publishing Corp, New York, pp 373–409
Mackey MC (1996) Mathematical models of hematopoietic cell replication and control. In: Othmer H, Adler F, Lewis M, Dallon J (eds) The art of mathematical modeling: case studies in ecology, physiology and biofluids. Prentice Hall, New York, pp 149–178
Mackey MC (2000) Cell kinetic status of haematopoietic stem cells. Cell Prolif 34:71–83
Mackey MC, Tyran-Kamińska M, Yvinec R (2013) Dynamic behavior of stochastic gene expression models in the presence of bursting. SIAM J Appl Math 73:1830–1852
Mahaffy J, Belair J, Mackey M (1998) Hematopoietic model with moving boundary condition and state dependent delay: applications in erythropoiesis. J Theor Biol 190:135–146
Makaryan V, Zeidler C, Bolyard A, Skokowa J, Kelley M, Boxer L, Bonilla M, Newburger P, Shimamura A, Welte K, Dale D (2012) Clinical outcomes for patients with severe chronic neutropenia due to mutations in the gene for neutrophil elastase, elane. Blood 120:3275
Marziliano N, Mannarino S, Nespoli L, Diegoli M, Pasotti M, Malattia C, Grasso M, Pilotto A, Porcu E, Raisaro A, Raineri C, Dore R, Maggio PP, Brega A, Arbustini E (2007) Barth syndrome associated with compound hemizygosity and heterozygosity of the TAZ and LDB3 genes. Am J Med Genet A 143A(9):907–915
Morley A (1970) Periodic diseases, physiological rhythms and feedback control-a hypothesis. Aust Ann Med 3:244–249
Morley A, Stohlman F (1970) Cyclophosphamide induced cyclical neutropenia. N Engl J Med 282:643–646
Morley A, King-Smith EA, Stohlman F (1969) The oscillatory nature of hemopoiesis. In: Stohlman F (ed) Hemopoietic cellular proliferation. Grune & Stratton, New York, pp 3–14
Morley AA, Carew JP, Baikie AG (1967) Familial cyclical neutropenia. Br J Haematol 13(5):719–738
Nanua S, Murakami M, Xia J, Grenda DS, Woloszynek J, Strand M, Link DC (2011) Activation of the unfolded protein response is associated with impaired granulopoiesis in transgenic mice expressing mutant Elane. Blood 117(13):3539–3547
Page AR, Good RA (1957) Studies on cyclic neutropenia: a clinical and experimental investigation. AMA J Dis Child 94(6):623–661
Palmer SE, Dale DC, Livingston RJ, Wijsman EM, Stephens K (1994) Autosomal dominant cyclic hematopoiesis: exclusion of linkage to the major hematopoietic regulatory gene cluster on chromosome 5. Hum Genet 93(2):195–197
Price TH, Chatta GS, Dale DC (1996) Effect of recombinant granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans. Blood 88(1):335–340
Reeve J (1973) An analogue model of granulopoiesis for the analysis of isotopic and other data obtained in the non-steady state. Br J Haematol 25:15–32
Reimann H, DeBerardinis CT (1949) Periodic (cyclic) neutropenia, an entity: a collection of 16 cases. Blood 4(10):1109–1116
Rosenberg PS, Alter BP, Bolyard AA, Bonilla MA, Boxer LA, Cham B, Fier C, Freedman M, Kannourakis G, Kinsey S, Schwinzer B, Zeidler C, Welte K, Dale DC (2006) The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. Blood 107(12):4628–4635
Rosenberg PS, Zeidler C, Bolyard AA, Alter BP, Bonilla MA, Boxer LA, Dror Y, Kinsey S, Link DC, Newburger PE, Shimamura A, Welte K, Dale DC (2010) Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy. Br J Haematol 150(2):196–199
Roskos LK, Lum P, Lockbaum P, Schwab G, Yang BB (2006) Pharmacokinetic/pharmacodynamic modeling of pegfilgrastim in healthy subjects. J Clin Pharmacol 46(7):747–757
Santillan M, Mahaffy J, Belair J, Mackey M (2000) Regulation of platelet production: The normal response to perturbation and cyclical platelet disease. J Theor Biol 206:585–603
Scargle JD (1982) Studies in astronomical time series analysis. II. Statistical aspects of spectral analysis of unevenly spaced data. Astrophys J 263:835–853
Schmitz S, Loeffler M, Jones JB, Lange RD, Wichmann HE (1990) Synchrony of bone marrow proliferation and maturation as the origin of cyclic haemopoiesis. Cell Tissue Kinet 23:425–441
Schmitz S, Franke H, Wichmann HE, Diehl V (1995) The effect of continuous G-CSF application in human cyclic neutropenia: a model analysis. Br J Haematol 90:41–47
von Schulthess GK, Fehr J, Dahinde C (1983) Cyclic neutropenia: amplification of granulocyte oscillations by lithium and long-term suppression of cycling by plasmapheresis. Blood 62:320–332
Shvitra D, Laugalys R, Kolesov YS (1983) Mathematical modeling of the production of white blood cells. In: Marchuk G, Belykh L (eds) Mathematical modeling in immunology and medicine. North-Holland, Amsterdam, pp 211–223
Swinburne J, Mackey M (2000) Cyclical thrombocytopenia: Characterization by spectral analysis and a review. J Theor Med 2:81–91
von Schulthess GK, Mazer NA (1982) Cyclic neutropenia (CN): a clue to the control of granulopoiesis. Blood 59:27–37
Wang B, Ludden TM, Cheung EN, Schwab GG, Roskos LK (2001) Population pharmacokinetic-pharmacodynamic modeling of filgrastim (r-metHuG-CSF) in healthy volunteers. J Pharmacokinet Pharmacodyn 28(4):321–342
Welte K, Platzer E, Lu L, Gabrilove JL, Levi E, Mertelsmann R, Moore MA (1985) Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor. Proc Natl Acad Sci USA 82(5):1526–1530
Wichmann HE, Loeffler M, Schmitz S (1988) A concept of hemopoietic regulation and its biomathematical realization. Blood Cells 14:411–429
Winfree AT (1980) The geometry of biological time. Biomathematics, vol 8. Springer-Verlag, Berlin
Wright DG, Dale DC, Fauci AS, Wolff SM (1981) Human cyclic neutropenia: clinical review and long-term follow-up of patients. Medicine (Baltimore) 60(1):1–13
Xia J, Link DC (2008) Severe congenital neutropenia and the unfolded protein response. Curr Opin Hematol 15(1):1–7
Zhuge C, Lei J, Mackey MC (2012) Neutrophil dynamics in response to chemotherapy and G-CSF. J Theor Biol 293:111–120
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dale, D.C., Mackey, M.C. Understanding, Treating and Avoiding Hematological Disease: Better Medicine Through Mathematics?. Bull Math Biol 77, 739–757 (2015). https://doi.org/10.1007/s11538-014-9995-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11538-014-9995-x